News & Events News Analysis Finds Anemia Drugs Raise the Risk of Death
December 31, 2007 Physicians Avert Cut to Medicare Payments January 9, 2008 Study Estimates 27,000 Deaths Resulted from Lack of Health Insurance in 2007 January 17, 2008 NPAF Urges Action on Expanded Access Read All |
Analysis Finds Anemia Drugs Raise the Risk of Death |
|
In the first meta-analysis of widely used anemia drugs, clinical trial data confirms that the risk of death among cancer patients is increased by approximately 10 percent. The lead author, Dr. Charles L. Bennett, a professor at Northwestern University, said the study shows a statistically significant increase in the risk of death from the drugs. On March 13th, the Food and Drug Administration (FDA) will convene an advisory committee meeting to discuss further restricting the use of these drugs which are used to treat anemia caused by cancer chemotherapy. Last year, the FDA was prompted to issue stronger warnings for the drugs after a series of studies were released suggesting that the products may be worsening cancer conditions or increasing the risk of death. Soon after, the Centers for Medicare & Medicaid Services (CMS) restricted reimbursement for the drugs. When the advisory committee meets in mid-March, one option that will likely be discussed will be whether to limit the use of these drugs to certain types of cancer and/or populations. |
| < Prev | Next > |
|---|
NPAF Election Center!
Do you know where each of the Presidential candidates stands on important health care issues? Would you like to attend a candidate event and support health care access issues? Visit the NPAF Election Center for candidate information and health care proposals.
